Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I131 MIBG and Topotecan in Refractory or Relapsed Metastatic Neuroblastoma
NCT00960739Phase 2Completed
- Sponsor
- Centre Oscar Lambret
- Start
- Nov 2008
- Primary completion
- Mar 2016
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of Iobenguane I-131, topotecan liposome in neuroblastoma, sponsored by Centre Oscar Lambret. Started Nov 2008; status: completed.
02
Drugs
Iobenguane I-131topotecan liposome
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT00960739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00960739.